Opto Circuits (India) intimates on favourable verdict for Cardiac Science Corporation

Image
Capital Market
Last Updated : Jun 08 2015 | 3:01 PM IST

In a case over wearable defibrillators technology

Opto Circuits (India) announced that its group company, Cardiac Science Corporation has won a long standing dispute over the company's wearable defibrillators technology. On 22 May 2015, the Los Angeles Superior Court unanimously decided in favor of the company's breach of contract claims against Zoll Medical Corporation, and Zoll LifeCor Corporation, awarding Cardiac Science Corporation nearly USD 23 million in lost royalties.

Powered by Capital Market - Live News

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 08 2015 | 1:20 PM IST

Next Story